Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.38 |
| ▸ | KDM5A | P29375 | 6/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.38 |
| ▸ | KDM4A | O75164 | 2/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9035334 | 0.92 | S1PR2 (0.42) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL5391134 | 0.90 | DNM1 (0.52) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL5405623 | 0.90 | DNM1 (0.52) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL5267531 | 0.89 | — | — | |
| SCHEMBL2303995 | 0.89 | — | — | |
| SCHEMBL28107821 | 0.88 | S1PR2 (0.41) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL11501695 | 0.88 | CHRM2 (0.43) | S1PR2S1PR1S1PR3S1PR5CHRM2 | |
| SCHEMBL19733122 | 0.86 | SIGMAR1 (0.39) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL9579289 | 0.86 | DNM1 (0.48) | S1PR2S1PR1S1PR3S1PR5KDM4C | |
| SCHEMBL15266038 | 0.85 | CA12 (0.44) | CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461375-B2 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | EVONIK RÖHM GMBH (DE) | 2013-06-11 | — | — | US | disclosed |
| EP-1583733-B1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | EVONIK ROEHM GMBH (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-1399409-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF SE (DE) | 2012-10-31 | — | — | EP | disclosed |
| US-20110178396-A1 | Nicotinamide Derivatives | CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD. (AU) | 2011-07-21 | — | — | US | disclosed |
| CN-100349854-C | Method for producing (meth) acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | disclosed |
| CN-100349851-C | Method for producing acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | disclosed |
| EP-1844052-A1 | THIENO[2,3-D]PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION | Pharmacia & Upjohn Company LLC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-7268251-B2 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-11 | — | — | US | disclosed |
| CN-1307146-C | Improved method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ROEHM GMBH (DE) | 2007-03-28 | — | — | CN | disclosed |
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ROEHM GMBH & CO. KG (DE) | 2006-09-21 | — | — | US | disclosed |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | US | disclosed |
| WO-2004063140-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2004-07-29 | — | — | WO | disclosed |
| CN-1514821-A | Method for producing acrylic acid esters | 巴斯福股份公司 | 2004-07-21 | — | — | CN | disclosed |
| EP-1399409-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-1399408-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-0870765-B1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002100814-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002100815-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
| US-5981557-A | HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0870765-A1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ADH5, ADH1A, ADH1C | S1PR2 2722/4885S1PR1 2878/4885S1PR3 2477/4885 |
| US-20110178396-A1 | Nicotinamide Derivatives | NAMPT, NNT, NNMT | S1PR2 2437/4885S1PR1 2641/4885S1PR3 2139/4885 |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | ADH1A, ADH5, ADH1C | S1PR2 1496/4885S1PR1 1803/4885S1PR3 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.